Lv4
496 积分 2024-04-21 加入
The evolving treatment landscape of metastatic urothelial cancer
1个月前
已完结
Antibody–drug conjugates for non-muscle invasive bladder cancer: current status and future development
1个月前
已完结
Nectin-4 Positivity in Genitourinary Malignancies: A Systematic Review
1个月前
已完结
Nectin-4 expression patterns and therapeutics in oncology
1个月前
已完结
Survival outcomes with enfortumab vedotin–containing regimens in metastatic urothelial carcinoma: A systematic review and meta-analysis
1个月前
已关闭
Nectin-4, Bladder Cancer, and Nuclear Medicine: A Theranostic Frontier
1个月前
已完结
Bone morphogenetic protein 1 as a macromolecular pan-cancer biomarker modulating the immune microenvironment and malignant phenotypes in glioblastoma
2个月前
已完结
Review of BCG immunotherapy for bladder cancer
3个月前
已完结
Identification of Differential Tumor Subtypes of T1 Bladder Cancer
5个月前
已完结
皖公网安备34019202002308
